Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Salestools Logo

Salestools

#1 AI-agent för säljteam och Go-to-Market-team. Sälj mer, snabbare, med mindre ansträngning.

Produkt

  • AI-säljagenter
  • Intentionsdata
  • Teknologidata
  • Besöksspårning
  • Medpilot
  • Social Försäljning

Lösningar

  • Kundservice
  • E-handel
  • SaaS
  • Företag
  • Småföretag

Resurser

  • Rapporten
  • Dokumentation
  • API-referens
  • Hjälpcenter
  • Blogg
  • Fallstudier
  • Webbinarier

Företag

  • Om oss
  • Karriärer
  • Press
  • Kontakt
  • Partners

Våra kontor

  • New York, HQ
  • Bukarest, AI-forskningslabb
  • Zug, Schweiz

© 2026 Salestools. Alla rättigheter förbehållna.

Datavillkor och SäkerhetSekretesspolicyAnvändarvillkorAcceptable Use
Alla system fungerar
Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Back to Reports
Fundraising

WellCare Health Plans

WellCare Health Plans Raises $20B in Public

8735 Henderson Road, Tampa, FL 33634January 1, 20242 min read
Employees
11000+

WellCare Health Plans Raises $20B in Public


WellCare Health Plans has successfully raised $20B in a Public at a $22B valuation led by Centene.


Company Overview


WellCare Health Plans is a Insurance company headquartered in 8735 Henderson Road, Tampa, FL 33634, founded in 1985 with 11000+ employees.


Managed care company


Fundraising Details


  • Amount Raised: $20B
  • Round Type: Public
  • Valuation: $22B
  • Date: 2024-01-01
  • Investors: Centene

About WellCare Health Plans


Managed care company The company is positioned in the Insurance sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 8735 Henderson Road, Tampa, FL 33634
  • Founded: 1985
  • Team Size: 11000+
  • Industry: Insurance

What This Means


This funding round demonstrates strong investor confidence in WellCare Health Plans's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Insurance sector continues to attract significant investment as companies innovate to meet evolving market demands. WellCare Health Plans's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $22B valuation marks an important milestone for WellCare Health Plans, positioning the company among notable players in the Insurance industry.


Looking Ahead


With this new capital, WellCare Health Plans is well-positioned to execute on its growth strategy and continue building innovative solutions in the Insurance space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about WellCare Health Plans, visit their headquarters at 8735 Henderson Road, Tampa, FL 33634.

Company Info

Headquarters
8735 Henderson Road, Tampa, FL 33634
Founded
1985
Team Size
11000+

Topics

Fundraising(2912)Public(771)InsuranceWellCare Health Plans

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free